| Lucy Bloe, FNP | |
|
491 E Alessandro Blvd, Riverside, CA 92508-6071 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | Lucy Bloe |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 491 E Alessandro Blvd, Riverside, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023299351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 17800 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucy Bloe, FNP 491 E Alessandro Blvd, Riverside, CA 92508-6071 Ph: (951) 212-3557 | Lucy Bloe, FNP 491 E Alessandro Blvd, Riverside, CA 92508-6071 Ph: (866) 389-2727 |
News Archive
Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).
The commission, established by Congress in January, faces some hurdles in getting a report done by September.
Juvenile arthritis (JA) is one of the most common, chronic childhood diseases in the U.S., affecting nearly 300,000 children. During Juvenile Arthritis Awareness Month, the Arthritis Foundation raises public awareness about this painful and debilitating disease—a disease that currently has no cure and can affect children for a lifetime.
A new report entitled Business Continuity Planning and Pandemic Influenza in Europe, published by the London School of Hygiene & Tropical Medicine (LSHTM), has found huge gaps and differences across Europe in the level of advice given to businesses to prepare for a possible influenza pandemic.
Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),
› Verified 6 days ago
Alice Chinyere Echeta, FNP, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4960 Arlington Ave Ste B, Riverside, CA 92504 Phone: 951-341-8930 | |
Obianuju Rivera, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3801 University Ave Ste 270, Riverside, CA 92501 Phone: 855-427-2778 Fax: 951-530-3997 | |
Luamy Gabriela Cornejo, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4440 Brockton Ave Ste 100, Riverside, CA 92501 Phone: 951-684-1293 | |
Christine Pham Duong, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5549 Van Buren Blvd, Riverside, CA 92503 Phone: 951-324-5901 Fax: 877-778-9472 | |
Namrata Nicole Sihotang, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 19330 Jesse Ln Ste 100, Riverside, CA 92508 Phone: 844-827-8000 | |
Helen Landayan Lo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7140 Indiana Avenue, Riverside, CA 92503 Phone: 951-358-6037 | |
Rebecca J Seawell, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 |